Eric L Simpson (Eric Simpson, E Simpson, E L Simpson)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 48

Top Topics

Atopic Dermatitis

Top Venues

Dermatology and therapy

Journal of the European Academy of Dermatology and Venereology : JEADV

Science advances

Health technology assessment (Winchester, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Eric L Simpson, Ben Lockshin, Lara Wine Lee, Zhen Chen, Moataz Daoud, Andrew Korotzer
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry. Dermatology and therapy 14 (1) (2024)
Zelma C Chiesa Fuxench, Wendy Smith Begolka, Eric L Simpson
Treatment satisfaction in adults with atopic dermatitis: a cross-sectional, population-based study examining patient and physician perspectives in the US. Archives of dermatological research 316 (6) (2024)
Lucy E Bradshaw, Laura A Wyatt, Sara J Brown, Rachel Helen Haines, Alan A Montgomery, Michael Richard Perkin, Tracey H Sach, Sandra Lawton, Carsten Flohr, Matthew J Ridd, Joanne R Chalmers, Joanne Brooks, Richard Swinden, Eleanor J Mitchell, Stella Tarr, Nicola Jay, Kim Suzanne Thomas, Hilary I Allen, Michael J Cork, Maeve M Kelleher, Eric L Simpson, Stella T Lartey, Susan Davies-Jones, Robert J Boyle, Hywel C Williams
Emollient application from birth to prevent eczema in high-risk children: the BEEP RCT. Health technology assessment (Winchester, England) 28 (29) (2024)
Jacob Pontoppidan Thyssen, Jonathan Ian Silverberg, J Ruano, Andrew Blauvelt, W Gubelin, Eric L Simpson, S Weidinger, H Valdez, K K Terry, P Biswas, E Güler, C Feeney
Optimizing maintenance therapy in responders to abrocitinib induction: A post hoc analysis of JADE REGIMEN. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Michael E Jacobson, R S Seshadri, Robert Bissonnette, Amy S Paller, S Weidinger, Jacob Pontoppidan Thyssen, B Hester, Eric L Simpson
Harmonizing body surface area assessments between the Eczema Area and Severity Index, SCORing Atopic Dermatitis, and handprint methods utilizing one shared measurement-A proposal to improve efficiency and reduce error in atopic dermatitis trials. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Eric L Simpson, Leon Kircik, Andrew Blauvelt, Howard Kallender, Daniel Sturm, Mingyue Wang, Lawrence F Eichenfield
Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies. Dermatology and therapy 14 (8) (2024)
Eric L Simpson, Ben Lockshin, Lara Wine Lee, Zhen Chen, Moataz Daoud, Andrew Korotzer
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry. Dermatology and therapy 14 (1) (2024)
Eric L Simpson, Ben Lockshin, Lara Wine Lee, Zhen Chen, Moataz Daoud, Andrew Korotzer
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry. Dermatology and therapy 14 (1) (2024)
Eric L Simpson, Ben Lockshin, Lara Wine Lee, Zhen Chen, Moataz Daoud, Andrew Korotzer
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry. Dermatology and therapy 14 (1) (2024)
Eric L Simpson, Vimal H Prajapati, Yael A Leshem, Raj Chovatiya, Marjolein de Bruin-Weller, Pamela Guglielmini, Andrew E Pink, Brian M Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M Platt, Jonathan Ian Silverberg
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2). Dermatology and therapy 14 (5) (2024)
Eric L Simpson, Leon Kircik, Andrew Blauvelt, Howard Kallender, Daniel Sturm, Mingyue Wang, Lawrence F Eichenfield
Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies. Dermatology and therapy 14 (8) (2024)
Eric L Simpson, Ben Lockshin, Lara Wine Lee, Zhen Chen, Moataz Daoud, Andrew Korotzer
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry. Dermatology and therapy 14 (1) (2024)
Eric L Simpson, Ben Lockshin, Lara Wine Lee, Zhen Chen, Moataz Daoud, Andrew Korotzer
Publisher Correction to: Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry. Dermatology and therapy (2024)
Eric L Simpson, Vimal H Prajapati, Yael A Leshem, Raj Chovatiya, Marjolein de Bruin-Weller, Pamela Guglielmini, Andrew E Pink, Brian M Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M Platt, Jonathan Ian Silverberg
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2). Dermatology and therapy 14 (5) (2024)
Lucy E Bradshaw, Laura A Wyatt, Sara J Brown, Rachel Helen Haines, Alan A Montgomery, Michael Richard Perkin, Tracey H Sach, Sandra Lawton, Carsten Flohr, Matthew J Ridd, Joanne R Chalmers, Joanne Brooks, Richard Swinden, Eleanor J Mitchell, Stella Tarr, Nicola Jay, Kim Suzanne Thomas, Hilary I Allen, Michael J Cork, Maeve M Kelleher, Eric L Simpson, Stella T Lartey, Susan Davies-Jones, Robert J Boyle, Hywel C Williams
Emollient application from birth to prevent eczema in high-risk children: the BEEP RCT. Health technology assessment (Winchester, England) 28 (29) (2024)
Eric L Simpson, Pablo Fernández-Peñas, Marjolein de Bruin-Weller, Peter A Lio, Chia-Yu Chu, Khaled Ezzedine, Helena Agell, Marta Casillas, Yuxin Ding, Fan Emily Yang, Evangeline Pierce, Thomas Bieber
Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2). Advances in therapy (2024)
Eric L Simpson, Leon Kircik, Andrew Blauvelt, Howard Kallender, Daniel Sturm, Mingyue Wang, Lawrence F Eichenfield
Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies. Dermatology and therapy (2024)
Lucy E Bradshaw, Laura A Wyatt, Sara J Brown, Rachel Helen Haines, Alan A Montgomery, Michael Richard Perkin, Tracey H Sach, Sandra Lawton, Carsten Flohr, Matthew J Ridd, Joanne R Chalmers, Joanne Brooks, Richard Swinden, Eleanor J Mitchell, Stella Tarr, Nicola Jay, Kim Suzanne Thomas, Hilary I Allen, Michael J Cork, Maeve M Kelleher, Eric L Simpson, Stella T Lartey, Susan Davies-Jones, Robert J Boyle, Hywel C Williams
Emollient application from birth to prevent eczema in high-risk children: the BEEP RCT. Health technology assessment (Winchester, England) 28 (29) (2024)
Lucy E Bradshaw, Laura A Wyatt, Sara J Brown, Rachel Helen Haines, Alan A Montgomery, Michael Richard Perkin, Tracey H Sach, Sandra Lawton, Carsten Flohr, Matthew J Ridd, Joanne R Chalmers, Joanne Brooks, Richard Swinden, Eleanor J Mitchell, Stella Tarr, Nicola Jay, Kim Suzanne Thomas, Hilary I Allen, Michael J Cork, Maeve M Kelleher, Eric L Simpson, Stella T Lartey, Susan Davies-Jones, Robert J Boyle, Hywel C Williams
Emollient application from birth to prevent eczema in high-risk children: the BEEP RCT. Health technology assessment (Winchester, England) 28 (29) (2024)
Eric L Simpson, Vimal H Prajapati, Yael A Leshem, Raj Chovatiya, Marjolein de Bruin-Weller, Pamela Guglielmini, Andrew E Pink, Brian M Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M Platt, Jonathan Ian Silverberg
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2). Dermatology and therapy (2024)
Michael E Jacobson, R Y Morimoto, Yael A Leshem, Laura M Howells, H C Williams, E Grinich, L A A Gerbens, P I Spuls, J Schmitt, B Staley, W Baghoomian, N Katoh, K S Thomas, Christian J Apfelbacher, Eric L Simpson
The Eczema Area and Severity Index: An update of progress and challenges in its measurement of atopic dermatitis after 20 years of use. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Eric L Simpson, Leon Kircik, Andrew Blauvelt, Howard Kallender, Daniel Sturm, Mingyue Wang, Lawrence F Eichenfield
Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies. Dermatology and therapy 14 (8) (2024)
Eric L Simpson, Ben Lockshin, Lara Wine Lee, Zhen Chen, Moataz Daoud, Andrew Korotzer
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry. Dermatology and therapy 14 (1) (2024)
Eric L Simpson, Ben Lockshin, Lara Wine Lee, Zhen Chen, Moataz Daoud, Andrew Korotzer
Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry. Dermatology and therapy (2024)
Eric L Simpson, Vimal H Prajapati, Yael A Leshem, Raj Chovatiya, Marjolein de Bruin-Weller, Pamela Guglielmini, Andrew E Pink, Brian M Calimlim, Wan-Ju Lee, Henrique Teixeira, Barry Ladizinski, Xiaofei Hu, Yang Yang, Yingyi Liu, Meng Liu, Ayman Grada, Andrew M Platt, Jonathan Ian Silverberg
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2). Dermatology and therapy 14 (5) (2024)
Zelma C Chiesa Fuxench, Wendy Smith Begolka, Eric L Simpson
Treatment satisfaction in adults with atopic dermatitis: a cross-sectional, population-based study examining patient and physician perspectives in the US. Archives of dermatological research 316 (6) (2024)
Eric L Simpson, K Rahawi, X Hu, A D Chu, C Nduaka, S Jazayeri, Peter A Lio, C Lynde, M L A Schuttelaar
Effect of Upadacitinib on Atopic Hand Eczema in Patients With Moderate-to-Severe Atopic Dermatitis: Results From Two Randomised Phase 3 Trials. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Mary C Moran, Alanna Klose, Takeshi Yoshida, Anna De Benedetto, Lynda C Schneider, Peck Y Ong, Eric L Simpson, Donald Y M Leung, Benjamin L Miller, Christopher L Seplaki, Lisa A Beck
History of S. aureus Skin Infection Significantly Associates with History of Eczema Herpeticum in Patients with Atopic Dermatitis. Dermatology and therapy (2023)
Robert Bissonnette, L F Eichenfield, Eric L Simpson, D Thaçi, K Kabashima, Jacob Pontoppidan Thyssen, E Guttman-Yassky, F P Nunes, M Gamalo, F Ahmad, M Kuligowski, K Sun, C Pipper, A W Christensen, P D'Angelo, M Milutinovic, A Guettner, Jonathan Ian Silverberg
Estimands for atopic dermatitis clinical trials: expert opinion on the importance of intercurrent events. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Jordan Zeldin, Prem Prashant Chaudhary, Jacquelyn Spathies, Manoj Yadav, Brandon N D'Souza, Mohammadali E Alishahedani, Portia Gough, Jobel Matriz, Andrew J Ghio, Yue Li, Ashleigh A Sun, Lawrence F Eichenfield, Eric L Simpson, Ian A Myles
Exposure to isocyanates predicts atopic dermatitis prevalence and disrupts therapeutic pathways in commensal bacteria. Science advances 9 (1) (2023)
Jacob Pontoppidan Thyssen, D Thaçi, T Bieber, Melinda J Gooderham, M de Bruin-Weller, W Soong, K Kabashima, Sébastien Barbarot, P C Luna, J Xu, X Hu, Y Liu, E M Raymundo, Brian M Calimlim, C Nduaka, A Gamelli, Eric L Simpson
Upadacitinib for moderate-to-severe atopic dermatitis: stratified analysis from three randomized phase 3 trials by key baseline characteristics. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Melinda J Gooderham, Andrew E Pink, Eric L Simpson, Jonathan Ian Silverberg, Erman Güler, Melissa Watkins
Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice. Dermatology and therapy (2023)
Jordan Zeldin, Prem Prashant Chaudhary, Jacquelyn Spathies, Manoj Yadav, Brandon N D'Souza, Mohammadali E Alishahedani, Portia Gough, Jobel Matriz, Andrew J Ghio, Yue Li, Ashleigh A Sun, Lawrence F Eichenfield, Eric L Simpson, Ian A Myles
Exposure to isocyanates predicts atopic dermatitis prevalence and disrupts therapeutic pathways in commensal bacteria. Science advances 9 (1) (2023)
Yael Renert-Yuval, Ester Del Duca, Bernd W M Arents, Robert Bissonnette, Aaron Mark Drucker, Carsten Flohr, Emma Guttman-Yassky, Dirk-Jan Hijnen, Kenji Kabashima, Yael A Leshem, Amy S Paller, Jonathan Ian Silverberg, Eric L Simpson, Phyllis Spuls, Christian L Vestergaard, Andreas Wollenberg, Alan D Irvine, Jacob Pontoppidan Thyssen
Treat-To-Target in Dermatology: A Scoping Review and International Eczema Council Survey on the Approach in Atopic-Dermatitis. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Jordan Zeldin, Prem Prashant Chaudhary, Jacquelyn Spathies, Manoj Yadav, Brandon N D'Souza, Mohammadali E Alishahedani, Portia Gough, Jobel Matriz, Andrew J Ghio, Yue Li, Ashleigh A Sun, Lawrence F Eichenfield, Eric L Simpson, Ian A Myles
Exposure to isocyanates predicts atopic dermatitis prevalence and disrupts therapeutic pathways in commensal bacteria. Science advances 9 (1) (2023)
Robert Bissonnette, L F Eichenfield, Eric L Simpson, D Thaçi, K Kabashima, Jacob Pontoppidan Thyssen, Emma Guttman-Yassky, F P Nunes, M Gamalo, F Ahmad, M Kuligowski, K Sun, C Pipper, A W Christensen, P D'Angelo, M Milutinovic, A Guettner, Jonathan Ian Silverberg
Estimands for atopic dermatitis clinical trials: Expert opinion on the importance of intercurrent events. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Eric L Simpson, Leon Kircik, Andrew Blauvelt, Howard Kallender, Yutzu Kuo, Haobo Ren, Daniel Sturm, Lawrence F Eichenfield
Clinically relevant improvements in adults and adolescents with atopic dermatitis who did not achieve Investigator's Global Assessment treatment success following 8 weeks of ruxolitinib cream monotherapy. The Journal of dermatology (2023)
M E Jacobson, R S Seshadri, R Morimoto, E Grinich, Carter K Haag, K Nguyen, Eric L Simpson
Early intervention and disease modification in atopic dermatitis-the current state of the field and barriers to progress. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Jordan Zeldin, Prem Prashant Chaudhary, Jacquelyn Spathies, Manoj Yadav, Brandon N D'Souza, Mohammadali E Alishahedani, Portia Gough, Jobel Matriz, Andrew J Ghio, Yue Li, Ashleigh A Sun, Lawrence F Eichenfield, Eric L Simpson, Ian A Myles
Exposure to isocyanates predicts atopic dermatitis prevalence and disrupts therapeutic pathways in commensal bacteria. Science advances 9 (1) (2023)
Robert Bissonnette, Eric L Simpson, Lawrence F Eichenfield, Emma Guttman-Yassky, Jonathan Ian Silverberg, Lisa A Beck, Lorena Mija, Jacob Pontoppidan Thyssen, Thomas Bieber, Kenji Kabashima, Elaine Siegfried, Georg Stingl, Peter Cornelis Maria van de Kerkhof, Gil Yosipovitch, Carle Paul, Amy S Paller
The vIGA-AD scale for atopic dermatitis: uptake in the past five years and position of the International Eczema Council. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Jordan Zeldin, Prem Prashant Chaudhary, Jacquelyn Spathies, Manoj Yadav, Brandon N D'Souza, Mohammadali E Alishahedani, Portia Gough, Jobel Matriz, Andrew J Ghio, Yue Li, Ashleigh A Sun, Lawrence F Eichenfield, Eric L Simpson, Ian A Myles
Exposure to isocyanates predicts atopic dermatitis prevalence and disrupts therapeutic pathways in commensal bacteria. Science advances 9 (1) (2023)
Jonathan Ian Silverberg, Eric L Simpson, Jacob Pontoppidan Thyssen, T Werfel, T Cardillo, S Colvin, E Pierce, Y Chen, S Chen, L Eichenfield
Long-Term Efficacy (up to 68 Weeks) of Baricitinib in Combination with Topical Corticosteroids in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Analysis of Treatment Responders, Partial Responders and Nonresponders Originating from Study BREEZE-AD7. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Lucy E Bradshaw, Laura A Wyatt, Sara J Brown, Rachel Helen Haines, Alan A Montgomery, Michael Richard Perkin, Sandra Lawton, Tracey H Sach, Joanne R Chalmers, Matthew J Ridd, Carsten Flohr, Joanne Brooks, Richard Swinden, Eleanor J Mitchell, Stella Tarr, Nicola Jay, Kim S Thomas, Hilary I Allen, Michael J Cork, Maeve M Kelleher, Eric L Simpson, Stella T Lartey, Susan Davies-Jones, Robert J Boyle, Hywel C Williams
Emollients for prevention of atopic dermatitis: 5-year findings from the BEEP randomized trial. Allergy (2022)
Mohamed A Kamal, John D Davis, Pavel Kovalenko, Kamal Srinivasan, Eric L Simpson, Takeshi Nakahara, Makoto Sugaya, Atsuyuki Igarashi, Marius Ardeleanu, Christine Xu, Kazuhiko Arima
Pharmacokinetics, pharmacodynamics, and exposure-efficacy of dupilumab in adults with atopic dermatitis. Clinical and translational science 15 (10) (2022)
Ji Young Ahn, Dong Heon Lee, Chan Ho Na, Dong Hyun Shim, Yu Sung Choi, Hye Jung Jung, Eric L Simpson
Facial erythema in patients with atopic dermatitis treated with Dupilumab - a descriptive study of morphology and Aetiology. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (11) (2022)
Jonathan Ian Silverberg, Eric L Simpson, Jacob Pontoppidan Thyssen, Thomas Werfel, Tracy E Cardillo, Stephanie Colvin, Evangeline Pierce, Yun-Fei Chen, Sherry Chen, Lawrence Eichenfield
Long-term efficacy (up to 68 weeks) of Baricitinib in combination with topical corticosteroids in adult patients with moderate-to-severe atopic dermatitis: Analysis of treatment responders, partial responders and nonresponders originating from study BREEZE-AD7. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Andreas Wollenberg, Lisa A Beck, Marjolein de Bruin-Weller, Eric L Simpson, Shinichi Imafuku, M Boguniewicz, R Zachariae, C K Olsen, Jacob Pontoppidan Thyssen
Conjunctivitis in adult patients with moderate-to-severe atopic dermatitis: results from five tralokinumab clinical trials. The British journal of dermatology (2021)
Eric L Simpson, Marjolein de Bruin-Weller, Ashish Bansal, Zhen Chen, Lauren Nelson, Diane Whalley, Randy Prescilla, Isabelle Guillemin, Dimittri Delevry
Definition of Clinically Meaningful Within-Patient Changes in POEM and CDLQI in Children 6 to 11 Years of Age with Severe Atopic Dermatitis. Dermatology and therapy 11 (4) (2021)